Orzetti, S.; Tommasi, F.; Bertola, A.; Bortolin, G.; Caccin, E.; Cecco, S.; Ferrarin, E.; Giacomin, E.; Baldo, P.
Genetic Therapy and Molecular Targeted Therapy in Oncology: Safety, Pharmacovigilance, and Perspectives for Research and Clinical Practice. Int. J. Mol. Sci. 2022, 23, 3012.
https://doi.org/10.3390/ijms23063012
AMA Style
Orzetti S, Tommasi F, Bertola A, Bortolin G, Caccin E, Cecco S, Ferrarin E, Giacomin E, Baldo P.
Genetic Therapy and Molecular Targeted Therapy in Oncology: Safety, Pharmacovigilance, and Perspectives for Research and Clinical Practice. International Journal of Molecular Sciences. 2022; 23(6):3012.
https://doi.org/10.3390/ijms23063012
Chicago/Turabian Style
Orzetti, Sabrina, Federica Tommasi, Antonella Bertola, Giorgia Bortolin, Elisabetta Caccin, Sara Cecco, Emanuela Ferrarin, Elisa Giacomin, and Paolo Baldo.
2022. "Genetic Therapy and Molecular Targeted Therapy in Oncology: Safety, Pharmacovigilance, and Perspectives for Research and Clinical Practice" International Journal of Molecular Sciences 23, no. 6: 3012.
https://doi.org/10.3390/ijms23063012
APA Style
Orzetti, S., Tommasi, F., Bertola, A., Bortolin, G., Caccin, E., Cecco, S., Ferrarin, E., Giacomin, E., & Baldo, P.
(2022). Genetic Therapy and Molecular Targeted Therapy in Oncology: Safety, Pharmacovigilance, and Perspectives for Research and Clinical Practice. International Journal of Molecular Sciences, 23(6), 3012.
https://doi.org/10.3390/ijms23063012
